Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-26 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-155 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-26 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-155 |
filingDate |
2012-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2014-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2014514356-A |
titleOfInvention |
Lixisenatide and metformin for the treatment of type 2 diabetes |
abstract |
The present invention refers to pharmaceutical combinations for blood glucose management in patients with type 2 diabetes. This relates to a combination of lixisenatide (AVEOOIO), a GLP-1 agonist, and metformin. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018503644-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7274258-B2 |
priorityDate |
2011-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |